Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.
Recombinant vaccines encoding strings of virus- or tumor-derived peptides and/or proteins are currently being designed for use against both cancer and infectious diseases. These vaccines aim to induce cytotoxic immune responses against several Ags simultaneously. We developed a novel tetramer-based...
主要な著者: | Palmowski, M, Choi, E, Hermans, I, Gilbert, S, Chen, J, Gileadi, U, Salio, M, Van Pel, A, Man, S, Bonin, E, Liljestrom, P, Dunbar, P, Cerundolo, V |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2002
|
類似資料
-
The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.
著者:: Hermans, I, 等
出版事項: (2004) -
High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
著者:: Choi, E, 等
出版事項: (2003) -
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
著者:: Salio, M, 等
出版事項: (2004) -
Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response.
著者:: Palmowski, M, 等
出版事項: (2004) -
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
著者:: Smith, C, 等
出版事項: (2005)